The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia

Neurochemistry International

Volumn 28, Issue 5-6, 1996, Pages 509-521

  Earley, Bernadette ^a   Canney, Mark ^a   Clune, Barbara ^a   Caldwell, Maeve ^a   Leonard, Brian E ^a   Junien, Jean Louis ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Institut de Recherche Jouveinal   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DIZOCILPINE; IFENPRODIL; IGMESINE; JO 1994; JO 1997; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; CEREBRAL INFARCTION; CINNAMATES; CYCLOPROPANES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; ISCHEMIC ATTACK, TRANSIENT; ISOQUINOLINES; MALE; MICE; MICE, INBRED STRAINS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; ORGANIC CHEMICALS; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTORS, SIGMA;

EID: 0029982452     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00144-1     Document Type: Article

References (41)

1. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. natn. Acad. Sci. U.S.A. 87, 9030-9033.
2. 3 ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration. Brain Res. 522, 275-289.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72, 248-254.
4. Bredt D. S. and Snyder S. H. (1990a) Isolation of nitric oxide synthase, a calmodulin requiring enzyme. Proc. natn. Acad. Sci. U.S.A. 87, 682-685.
5. Bredt D. S., Hwang P. M. and Snyder S. H. (1990b) Localisation of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
6. Buchan A. M. (1990) Do NMDA antagonists protect against cerebral ischaemia: are clinical trials warranted? Cerebrovasc. Brain Metab. Rev. 2, 1-26.
7. Buchanan J. E. and Phillis W. (1993) The role of nitric oxide in the regulation of cerebral blood flow. Brain Res. 610, 248-255.
8. G-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil. Eur. J. Pharmac. 260, 191-200.
9. Carter C., Benavides J., Legendre P., Vincent J.-D., Noel F., Thuret F., Lloyd K. G., Arbilla S., Zokovic B., MacKenzie E. T., Scatton B. and Langer S. Z. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence of N-methyl-D-aspartate receptor antagonist properties. J. Pharmac. exp. Ther. 247, 1222-1232.
10. Choi D. W. (1992) NMDA receptors, AMPA receptors, and extracellular acidity in ischemic brain damage: a view from the dish. In: Pharmacology of Cerebral Ischaemia (Krieglestein J. and Oberpichler-Schwenk H., eds). pp. 45-52. Wissenschaftliche Verlagsgesellschaft mbh, Stuggart.
11. Dawson T. M. and Snyder S. H. (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 10(9), 5147-5159.
12. Debonnel G., Monnet F. P., Junien J.-L. and DeMontigny C. (1990) Further evidence for the modulation of the excitatory effect of NMDA by sigma receptor ligand. FASEB 4, A330.
13. 2 muscarinic receptor subtypes in trimethyltin treated rats. Neurochem. Int. 26, 559-570.
14. Earley B., Canney M., O'Neill M., Leonard B. E. and Junien J.-L. (1995b) Experimental cerebral ischaemia in mongolian gerbils: effects of JO 1784 on histological parameters and locomotor activity. Soc. Neurosci. Abstr. 19, 1644.
15. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends. Neurosci. 14, 60-57.
16. Gill R., Andine P., Hillered L., Peterson L. and Hafberg H. (1992) The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat. J. Cereb. Blood Flow Metab. 12, 371-379.
17. Gotti B., Duverger D., Bertin J., Carter C., Dupon R., Frost J., Gaudilliere B., MacKenzie E. T., Rousseau J., Scatton B. and Wick A. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmac. exp. Ther. 247, 1211-1221.
18. Gotti B., Benavides J., MacKenzie E. T. and Scatton B. (1990) The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 522, 290-307.
19. Grotta J. C., Picone C. M., Ostrow P. T., Strong R. A., Ears R. M., Yao L. P., Rhoades H. M. and Dedman J. R. (1990) CGS-19755, a competitive NMDA receptor antagonist, reduces calcium calmodulin binding and improves outcome after global cerebral ischaemia. Ann. Neural. 27, 612-617.
20. Kader A., Frazzini V. I., Solomon R. A. and Trifiletti R. R. (1993) Nitric oxide production during focal cerebral ischemia in rats. Stroke 24, 1709-1715.
21. Kerwin J. F. and Heller M. (1994) The arginine nitric oxide pathway: a target for new drugs. Med. Res. Rev. 14, 23-74.
22. Kumura E., Kosaka H., Shiga T., Yoshimine T. and Hayakawa T. (1994) Elevation of plasma nitric oxide end products during focal cerebral ischaemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 14, 487-491.
23. Langer S. Z. and Arbilla S. (1988) Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor. Pharmac. Biochem. Behav. 29, 763-766.
24. Lockhart B. P., Soulard P., Benicourt C., Privat A. and Junien J.-L. (1995) Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675, 110-120(a).
25. Lysko P. G., Yue T.-L., Gu J.-L. and Feuerstein G. (1992a) Neuroprotective mechanism of (±) SKF 10,047 in vitro and in gerbil global ischemia. Stroke 23, 1319-1324.
26. Lysko P. G., Gagnon R. C., Yue T.-L., Gu J.-L. and Feuerstein G. (1992b) Neuroprotective effects of (±) SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischaemia. Stroke 23, 414-419.
27. Malinsky T., Bailey F., Zhang Z. G. and Chopp M. (1993) Nitric oxide measured with a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13, 355-360.
28. McCulloch J., Bullock R. and Teasdale G. M. (1991) Excitatory amino acid antagonists: opportunities for the treatment of ischaemic brain damage in man. In: Excitatory Amino Acid Antagonists (Meldrum B. S., ed.), pp. 287-326. Blackwell, London.
29. Meldrum B. (1989) Excitotoxicity in ischemia: an overview. In: Cerebrovascular Diseases - Sixteenth Research (Princeton) Conference (Ginsberg, M. D. and Dietrich W. D., eds), pp. 47-60. Raven Press, New York.
30. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends pharmac. Sci. 11, 379-387.
31. Moncada C., Lakieffre D., Arvin B. and Meldrum B. (1992) Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. Neuroreport 3, 530-532.
32. Monnet F. P., Debonnel G., Junien J.-L. and de Montigny C. (1990) N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur. J. Pharmac. 179, 441-445.
33. 3H]noradrenaline release in the rat hippocampus: g-protein dependency. Naunyn-Schmeidebergs Arch. Pharmac. 346, 32-39.
34. O'Neill M., Canney M., Earley B., Junien J.-L. and Leonard B. E. (1996) The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochem. Int. 28, 193-207.
35. Poignet H., Nowicki J. P. and Scatton B. (1992) Lack of neuroprotective effect of some a ligands in a model of focal cerebral ischemia in the mouse. Brain Res. 596, 320-324.
36. Roman F. J., Pascaud X., Duffy O. and Junien J.-L. (1991) Modulation by neuropeptide Y and peptide YY of NMDA effects of hippocampal slices: role of sigma receptors, NMDA receptor related agents. In: Biochemistry, Pharmacology and Behaviour (Kameyama J.-M., Nabeshima T. and Domino E. F., eds), pp. 211-218. NPP Books, Ann Arbor.
37. Roman F. J., Pascaud X., Brunelle G., Martin B. and Junien J.-L. (1992) Effect of JO 1784, a potent and specific sigma ligand on cholinergic function. Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection? (Kameyama J.-M. and Domino E. F., eds), pp. 555-559. NPP Books, Ann Arbor.
38. Rothman S. M. and Olney J. W. (1986) Glutamate and the pathophysiology of hypoxic-ischaemic brain damage. Ann. Neurol. 19, 105-111.
39. Scatton B., Carter C., Benavides J. and Giroux C. (1991) N-Methyl-D-aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc. Dis. 1, 121-135.
40. Welsh F. A., Sakamoto T., McKee A. E. and Sim R. (1987) Effect of lactacidosis on pyridine nucleotide stability during ischaemia in mouse brain. J. Neurochem. 49, 846-851.
41. Winer B. J. (1962) Statistical Principles in Experimental Design. McGraw-Hill, New York.